Clinical Trials
4 trialsNCT05864846 2026-04-27
EpiCom
Jazz Pharmaceuticals
Phase 4 Completed
NCT06533657 2026-04-21
UTOPIA-1
ZYUS Life Sciences Inc.
Phase 2 Completed
NCT02544763 2022-09-28
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Jazz Pharmaceuticals
Phase 3 Completed
NCT02544750 2022-07-14
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Jazz Pharmaceuticals
Phase 3 Completed